ACB $1.600 (-4.19%)

ACNNF $0.170 (-13.87%)

AERO $1.560 (0.32%)

AGEEF $0.115 (3.46%)

ALEAF $0.441 (-1.74%)

AMMJ $0.115 (0.35%)

APHA $3.983 (-3.8%)

ARNA $52.690 (-1.01%)

ATT:CNX $0.080 (0%)

ATTBF $0.010 (9.27%)

AUSA:CNX $0.255 (-3.77%)

AUSAF $0.205 (-18.2%)

AVXL $5.090 (-1.36%)

BAMM:CNX $0.420 (-1.18%)

BBM:CNX $0.095 (-5%)

BBRRF $0.080 (5.26%)

BE:CNX $0.025 (-16.67%)

BIO:CNX $0.080 (0%)

BLEVF $0.020 (-33.33%)

BLO:CNX $0.610 (-4.69%)

BLOZF $0.467 (3.55%)

BUDZ $0.307 (-3.97%)

BXNG $0.390 (21.84%)

CADMF $0.638 (6.3%)

CALI:CNX $0.090 (0%)

CANN $0.600 (-0.81%)

CARA $17.230 (0.17%)

CBII:CNX $0.120 (0%)

CBIIF $0.098 (8.89%)

CBWTF $0.429 (0.16%)

CGC $20.800 (-4.94%)

CGRW $0.155 (-3.73%)

CHOO:CNX $0.135 (-3.57%)

CHOOF $0.107 (-3.34%)

CNAB $0.132 (-5.31%)

CNBX $0.389 (-5.24%)

CNGGF $0.705 (-4.08%)

CODI $21.064 (-1.85%)

CPMD $1.330 (0.76%)

CRBP $5.490 (-3.17%)

CRON $7.150 (-2.59%)

CRTPF $2.660 (-6.01%)

CRXPF $0.101 (6.21%)

CSI:CNX $0.890 (-1.11%)

CTST $0.790 (-4.65%)

CURR $2.360 (3.08%)

CVSI $0.870 (-1.15%)

DIGP $0.087 (7.47%)

DXBRF $0.155 (-1.59%)

EAPH $0.001 (-18.18%)

EAT:CNX $0.035 (16.67%)

EEVVF $0.096 (-0.21%)

EMHTF $0.179 (-0.22%)

EPWCF $0.023 (-8.16%)

EVIO $0.063 (-3.38%)

FFRMF $0.026 (-11.86%)

FFT:CNX $0.035 (-12.5%)

FNNZF $0.079 (0%)

GGTTF $0.115 (2.77%)

GLDFF $0.016 (-13.41%)

GLH:CNX $0.020 (-20%)

GLNNF $0.140 (24.44%)

GNBT $0.620 (-1.59%)

GRIN:CNX $0.095 (0%)

GRWG $6.220 (-2.96%)

GSTR:CNX $0.060 (0%)

GTBIF $8.580 (-3.08%)

GTII:CNX $10.870 (-3.98%)

GWPH $125.690 (-2.23%)

HEXO $1.355 (-3.9%)

HHPHF $0.020 (0%)

HLSPY $0.540 (0%)

HMLSF $6.536 (-1.59%)

HMPPF $0.498 (0%)

HRVOF $0.071 (-8.9%)

HSTRF $0.120 (1.52%)

HUGE:CNX $7.830 (0%)

IAN:CNX $1.580 (0%)

IGC $0.570 (-0.87%)

IGXT $0.405 (-1.17%)

IIPR $102.180 (-3.22%)

IMLFF $0.250 (0%)

INQD $0.001 (0%)

IONC:CNX $0.020 (0%)

IONKF $0.015 (-20.63%)

ISOL:CNX $0.185 (2.78%)

ISOLF $0.148 (-0.2%)

ITHUF $1.210 (-4.7%)

IVITF $0.042 (7.97%)

JWCAF $0.146 (-6.54%)

KALTF $0.031 (3.33%)

KBEV:CNX $0.180 (16.13%)

KBEVF $0.115 (4.82%)

KHRNF $0.490 (-3.98%)

KSHB $1.360 (-2.86%)

LHS:CNX $0.630 (-3.08%)

LHSIF $0.500 (-4.3%)

LOVE:CNX $0.130 (0%)

LXLLF $0.380 (0%)

LXRP $0.480 (-2.04%)

LXX:CNX $0.600 (-4.76%)

MCIG $0.058 (-4.17%)

MDCL $2.330 (5.43%)

MEDIF $2.190 (-8.18%)

MGWFF $0.060 (-14.29%)

MICWF $0.035 (0.29%)

MJ:CNX $0.130 (-3.7%)

MJNA $0.019 (-2.07%)

MNTR $0.125 (-3.85%)

MRRCF $0.008 (0.63%)

MWM:CNX $0.050 (0%)

MYM:CNX $0.080 (-5.88%)

MYMMF $0.065 (-2.33%)

NCNNF $0.216 (-18.65%)

NDVAF $0.283 (-16.71%)

NGW:CNX $0.085 (0%)

NRXCF $0.044 (-3.24%)

NSPDF $0.047 (-1.46%)

NTEC $0.286 (2.11%)

NVTQF $0.161 (17.37%)

NWKRF $0.424 (0%)

NXGWF $0.070 (-0.07%)

NXTTF $0.356 (-1.41%)

ORHOF $4.050 (0%)

OWCP $0.043 (-6.83%)

PHGRF $0.336 (-1.12%)

PHVAF $0.093 (25.37%)

PILL:CNX $0.510 (2%)

PKG:CNX $0.100 (0%)

PLPRF $0.812 (0.06%)

PLUS:CNX $0.970 (-9.35%)

PMCB $0.054 (0.94%)

PNPL $0.690 (0%)

POTN $0.025 (-1.96%)

PRCNF $0.052 (-2.08%)

PTNYF $0.084 (-0.24%)

QCA:CNX $0.095 (0%)

RDDTF $0.271 (-0.95%)

RLLVF $0.017 (26.1%)

RMHB $0.036 (-0.28%)

RQB:CNX $0.040 (0%)

RQHTF $0.449 (1.75%)

RVVQF $0.032 (28.8%)

SLNG:CNX $0.295 (-6.35%)

SMG $118.870 (-1.48%)

SNN:CNX $0.220 (0%)

SNNVF $0.180 (-2.7%)

SOL:CNX $0.310 (-8.82%)

SOLCF $0.256 (16.14%)

SPLIF $0.024 (-14.91%)

SPRWF $0.296 (-1.27%)

SRNA $0.069 (-1.43%)

STEM:CNX $1.190 (-0.83%)

STMH $0.910 (-1.09%)

SUN:CNX $0.160 (-8.57%)

TBPMF $0.294 (-7.26%)

TCAN:CNX $0.980 (-12.5%)

TCNAF $0.803 (14.71%)

TER:CNX $2.890 (-2.03%)

TGEN $2.020 (-0.98%)

TGIF:CNX $0.175 (0%)

TGIFF $0.135 (-3.57%)

THC:CNX $0.145 (0%)

THCBF $0.113 (5.41%)

TLRY $19.370 (0.68%)

TOKI:CNX $0.035 (-22.22%)

TRLFF $0.107 (5.68%)

TRPX $0.491 (-1.78%)

TRSSF $2.280 (-0.87%)

TRTC $0.153 (-3.9%)

TURV $0.051 (20.24%)

VBIO $0.050 (0%)

VIDA:CNX $0.100 (-4.76%)

VIN:CNX $0.025 (66.67%)

VPRB $0.031 (28.01%)

VRNDF $0.448 (-2.53%)

VRT:CNX $0.120 (0%)

VRTHF $0.080 (-9.09%)

VVCIF $0.257 (-13.23%)

WAYL:CNX $0.740 (0%)

WDDMF $0.435 (-3.85%)

WLDFF $0.130 (-3.85%)

XXII $0.935 (-3.06%)

ZDPY $0.206 (-5.37%)

ZYNE $4.920 (2.29%)

Technical420 Site Search

Returned 21 result(s).

Relevium Announces Update Call for Shareholders

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF and Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce a shareholder information video-conference call to provide an update on the current business and ongoing developments disclosed to the market. CEO VIDEOCONFERENCE CALL DETAILS The CEO video-conference call will take this Friday February 7 at 12:00PM (Montreal or…

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which will provide pediatric customers with the ability to obtain free legal representation to seek reimbursement for the costs of medical…

Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”) announced today it is positioning itself as an important player in the Colombian medical cannabis market  by cementing medical and research relationships in the country in order to…

Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned subsidiary Biocannabix Health Corporation (“Biocannabix”) has executed an LOI to acquire 30% of Weedsense Inc., a late stage applicant for standard processing and medical sales license. WEEDSENSE STRATEGIC FIT…

Relevium Technologies Is In Full Growth Mode

During the last year, there have been significant changes in the landscape of the cannabis industry and this has created new opportunities for companies. Cannabidiol (CBD) has been an attractive vertical of the cannabis industry as it has been experiencing rapid growth and this is an opportunity we have been…

5 Cannabis Stocks Levered To The CBD Boom

The cannabis industry is the world’s fastest growing industry, and this has created significant opportunities for investors. Over the next year, we expect to see significant consolidation in the cannabis industry and this is something we are monitoring closely. Hemp has the potential to disrupt several prominent industries: advanced materials,…

Relevium Technologies Continues To Advance It’s CBD and THC Business Units

The legal cannabis market is gaining significant traction all over the world and Canada has been leading the charge. Demand for cannabis products continues to increase and this is a trend that is just getting started. Although this trend is exciting, Canadian cannabis stocks have been under pressure and we…

Relevium Technologies Is In Expansion Mode

Demand for products that contain cannabidiol (CBD) continues to increase and this is a trend that is benefiting the companies levered to this burgeoning market.One of the main factors driving the increased demand for CBD products is the number of countries that allow for the sale of such products. 2018…

Relevium Announces Strategic Investment in Leading Pediatric Cannabis Company and Obtains Exclusive License for the Canadian Market

Relevium Technologies Inc. (TSX.V:  “RLV”, OTCQB: “RLLVF”), is pleased to announce that it has executed a binding letter of intent for a strategic investment into CannaKids.org for an initial 25% equity. Cannakids is a leader in the medical cannabis patient research and consumer product development for pediatric and adult applications.Strategic Focus…

Relevium’s Bioganix® Now Live on Amazon.co.uk

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF”) is pleased to announce that the Bioganix® brand is now available for purchase in the United Kingdom (“UK”) on the Amazon.co.uk platform.As announced on April 5, 2018, the Company has begun selling its Bioganix® nutraceutical products in the UK. The Company experienced some…

Older Posts »

Search Again